Sight Sciences Names Dr. Reay H. Brown as Chief Medical Officer

By

Reay H. Brown, MD.
MENLO PARK, Calif.—Sight Sciences, Inc.,  a growth-stage medical device company for ophthalmology and optometry, glaucoma and dry eye treatment, has named Reay H. Brown, MD, as chief medical officer, according to an announcement from the company. Dr. Brown is a prolific inventor of surgical glaucoma. He was the original inventor of trabecular microbypass stenting, which has served as the foundation for the micro-invasive glaucoma surgery (MIGS) industry. Over his career, Dr. Brown has published 90 peer reviewed articles on glaucoma and cataract surgery, and has served in prominent thought leadership positions including as chairman of the American Society of Cataract and Refractive Surgery’s (ASCRS) Glaucoma Committee.

Dr. Brown remains a practicing board-certified ophthalmologist with more than 30 years of experience, specializing in glaucoma, glaucoma surgery, and cataract surgery. He served as the director of the Glaucoma Service at Emory Eye Center for 11 years prior to entering private practice as a founding partner of Atlanta Ophthalmology Associates in 1999.

“We are extremely proud to add someone who I consider to be one of the true pioneers in the history of modern ophthalmology to our executive team,” said CEO Paul Badawi. “Dr. Brown’s vast experience, both as a practicing surgeon and as a prolific product innovator, aligns perfectly with our company’s core competencies and, on behalf of everyone at Sight Sciences, we could not be more thrilled about Dr. Brown joining the company and furthering our mission.”

“I am thrilled to join Sight Sciences as chief medical officer,” said Dr. Brown. “I have known the leadership team for many years and have become intimately familiar with the company’s product portfolio. I look forward to making improvements to the existing product portfolio whenever possible, developing new products, and assisting the clinical and commercial teams.”